Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 ORAL Beverly Hills Rejuvenation Center FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences